XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Dec. 29, 2024
Mar. 31, 2024
Dec. 31, 2023
Dec. 29, 2024
Dec. 31, 2023
Mar. 31, 2024
Cash flows from operating activities            
Net earnings $ 114,812   $ 76,158 $ 267,189 $ 208,184  
Adjustments to reconcile net earnings to net cash provided by operating activities:            
Depreciation and amortization       74,377 68,304  
Write-off of assets relating to exit activities       342 21,506  
Impairment of indefinite-lived intangibles 0   6,020 0 6,020  
Derivatives not designated in hedging relationships:            
Net losses (gains)       (1,765) 666  
Cash (settlements) proceeds       763 (203)  
Provision for doubtful accounts       1,914 1,912  
Deferred income taxes       68 (258)  
Non-cash interest expense       1,448 1,229  
Stock-based compensation       20,263 22,894  
(Gain) loss on disposal of property, plant, and equipment       69 644  
Changes in assets and liabilities:            
Accounts receivable       (24,206) 139,508  
Inventories       (19,567) 27,401  
Prepaid and other current assets       (145,466) (3,602)  
Other assets       1,054 (1,343)  
Accounts payable       (17,739) (45,650)  
Accrued expenses       (34,786) (126,857)  
Other liabilities       1,152 (108)  
Net cash provided by (used in) operating activities       125,110 320,247  
Cash flows from investing activities            
Capital expenditures       (90,765) (59,005)  
Purchase of business       (206,024) (8,270)  
Proceeds from disposal of property, plant, and equipment       94 2,037  
Investment in Equity Securities       (10,852) 0  
Net cash (used in) provided by investing activities       (307,547) (65,238)  
Cash flows from financing activities            
Net (repayments) borrowings on short-term debt       951 (440)  
Proceeds from Second Amended Revolver borrowings       650,000 182,500  
Repayments of Second Amended Revolver borrowings       (180,000) (327,500)  
Repayments of Second and Third Amended Term Loans       0 (19,116)  
Option proceeds, net       7,641 9,668  
Payment of taxes related to net share settlement of equity awards       (7,984) (9,492)  
Purchase of treasury stock       (113,928) (82,331)  
Dividends paid to stockholders       (28,060) (25,423)  
Other       233 910  
Net cash provided by (used in) financing activities       328,853 (271,224)  
Effect of exchange rate changes on cash and cash equivalents       (16,576) 2,264  
Net increase (decrease) in cash and cash equivalents       129,840 (13,951)  
Cash and cash equivalents at beginning of period   $ 332,714   333,324 346,665 $ 346,665
Cash and cash equivalents at end of period $ 463,164 $ 333,324 $ 332,714 $ 463,164 $ 332,714 $ 333,324